Anzeige
Mehr »
Login
Sonntag, 24.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 22.03.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
22.03.Rubicon Technologies, Inc. Receives Notice of Non-Compliance with NYSE Trading Share Price and Market Capitalization Listing Rules378NEW YORK--(BUSINESS WIRE)--Rubicon Technologies, Inc. ("Rubicon" or the "Company") (NYSE: RBT), a leading provider of technology solutions for waste, recycling, and fleet operations, today announced...
► Artikel lesen
22.03.Axonics Stockholders Approve Merger Agreement with Boston Scientific225IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics' merger agreement with Boston Scientific Corporation (NYSE: BSX)....
► Artikel lesen
22.03.Amen Properties Reports Results for Fourth Quarter of 2023 and Announces Dividend130DALLAS--(BUSINESS WIRE)--Amen Properties, Inc. (Pink Sheets: AMEN) today announced financial results for its fiscal year ended December 31, 2023. The Company posted revenue of $3.7 million and...
► Artikel lesen
22.03.Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023228SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained...
► Artikel lesen
22.03.Daiichi Sankyo: CHMP gibt positive Stellungnahmen für Bempedosäure und die Bempedosäure/Ezetimib-Kombinationstablette zur Behandlung von Hypercholesterinämie und zur signifikanten Verringerung kardiovaskulärer Ereignisse ab1.099Die positiven Stellungnahmen des CHMP beruhen auf den Analysen der Phase-3-Studie CLEAR (Cholesterol Lowering via Bempedoic Acid, an ATP citrate lyase (ACL)-Inhibiting Regimen) Outcomes. 1 ...
► Artikel lesen
22.03.Kroll Bond Rating Agency, LLC: KBRA Assigns Preliminary Ratings to Roundstone Securities No.2 DAC2.716KBRA Europe (KBRA) assigns preliminary ratings to six classes of notes issued by Roundstone Securities No.2 DAC (Roundstone 2). The transaction is a static RMBS securitisation backed by seasoned performing...
► Artikel lesen
22.03.Hamilton Global Opportunities plc Published Its 2023 Full-Year Financial Results and Activity Report460Highlights for 2023: Focus on portfolio management Additional investment in Gauzy Ltd a world leader in smart glass and ADAS technologies in March 2023 Financial elements:...
► Artikel lesen
22.03.AM Best Affirms Credit Ratings of CICA-RE257AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of "bbb-" (Good) of Compagnie Commune de Réassurance des Etats Membres de la CIMA (CICA-RE)...
► Artikel lesen
22.03.Curaleaf International kommentiert die schnelle Verabschiedung des deutschen Bundes-Cannabisgesetzes462Heute wurde bekannt gegeben, dass das Cannabisgesetz der deutschen Bundesregierung, auch bekannt als Säule 1, erfolgreich und ohne Verzögerung vorangekommen ist. Nach dem positiven Ausgang der Abstimmung...
► Artikel lesen
22.03.BM3EAC Corp. Vereinbarung mit Arkon Energy326BM3EAC Corp. (das "Unternehmen"), eine nach dem Recht der Kaimaninseln gegründete und an der Euronext Amsterdam, dem von der Euronext Amsterdam N.V. betriebenen geregelten Markt, notierte Mantelgesellschaft...
► Artikel lesen
22.03.Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com713The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical clinical development landscape...
► Artikel lesen
22.03.GenSight Biologics Reports Full Year 2023 Consolidated Financial Results375PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative...
► Artikel lesen
22.03.Veolia Environnement: Availability of the 2023 Universal Registration Document / Annual Financial Report (French version)457Regulatory News: Veolia Environnement (Paris:VIE) announces that the French version of the 2023 Universal Registration Document ("URD") was filed on March 21,2024 with the French Financial Markets...
► Artikel lesen
22.03.GenSight Biologics S.A.: GenSight Biologics Reports Full Year 2023 Consolidated Financial Results312Efforts to reduce operational expenses confirming the cash runway until the end of April 2024 Mobilization of resources aimed at releasing the batch of LUMEVOQ® Drug Product expected in...
► Artikel lesen
22.03.Gilead Sciences Announces Completion of Acquisition of CymaBay189FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq:...
► Artikel lesen
22.03.American Realty Investors, Inc. reports Earnings for Quarter Ended December 31, 2024200DALLAS--(BUSINESS WIRE)--American Realty Investors, Inc. (NYSE:ARL) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended December 31, 2023...
► Artikel lesen
22.03.Transcontinental Realty Investors, Inc. reports Earnings for Quarter Ended December 31, 2023148DALLAS--(BUSINESS WIRE)--Transcontinental Realty Investors, Inc. (NYSE:TCI) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended December 31...
► Artikel lesen
22.03.Income Opportunity Realty Investors, Inc. Reports Earnings for Quarter Ended December 31, 2023143DALLAS--(BUSINESS WIRE)--Income Opportunity Realty Investors, Inc. (NYSE American:IOR) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended...
► Artikel lesen
22.03.CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans388Final maturity of all bank loans extended by at least 2 years Equitization of the loan contracted with the EIB to reduce its repayment in cash and optimize the Company's cash position Regulatory...
► Artikel lesen
22.03.University of Phoenix Leadership Join Proceedings of 2024 Mediterranean Region Counseling Association Conference474College of Social and Behavioral Sciences Associate Dean, Sheila Babendir, Ed.D., LPC, and Program Chair, Christine Karper, Ph.D., LMHC present on counselor education for a global society University...
► Artikel lesen
Seite:  Weiter >>